Rare diseases
Investigational molecules
Locations
Study of pembrolizumab and lenvatinib treatment for patients with vulvar cancer
ItalyStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
GermanyStudy of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer
BelgiumStudy of obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate rituximab
FranceLong-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease
BelgiumSafety Study of Regulatory T Cells (TREG02) and Tacrolimus Discontinuation in Adult Liver Transplant Recipients
GermanyStudy of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis
BelgiumStudy of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement
SpainStudy of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever
NorwayStudy of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma
GermanyComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
BulgariaStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
